• Royal DSM to Cut 1,000 Jobs as Chief Strives to Meet Profit Goals More...

• Elan Corporation PLC (ELN) Faces an Even Shakier Future More...

• Pharming Group (PHGUF.PK) Draws First Tranche Under EUR10 Million Working Capital Facility More...

• MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) to Acquire Pracinostat for Up to $75.2 Million More...

• Warner Chilcott, PLC (WCRX) Ends Talks With Possible Buyers More...

• Bristol-Myers Squibb Company (BMY) Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc. (AMLN) More...

• DSM Buys Brazil Animal Nutrition Firm for 465 Million Euros More...

• Dudnyk Expands Offering Via Strategic Acquisition More...

• Lundbeck Inc. (LUN.CO) in Talks With Possible Alzheimer's Drug Partners More...

• Synthetic Biologics, Inc. (AEN) and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases More...

• Mylan Specialty, Pfizer Inc. (PFE) Sign EpiPen Injection Licensing Deal in Japan More...

• Islet Sciences Announces Strategic Alliance With Spring Point Project More...

• CollabRx Teams With MedPage Today to Introduce Digital Tool for Patient-Specific Genomic Approaches to Cancer Treatment More...

• AnaptysBio, Inc. Expands Leadership Team With Addition of Dr. Andrew J. Mcknight More...

• Lundbeck Inc. (LUN.CO) Posts Second-Quarter Loss on Restructuring Charge More...

• Apricus Biosciences (APRI) Announces Second Quarter 2012 Financial Results Conference Call and Provides Corporate Update More...

• Aegerion Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results More...

• Achillion Pharmaceuticals, Inc. (ACHN) Reports Second Quarter and Six Month 2012 Financial Results More...

• Amicus Therapeutics, Inc. (FOLD) Announces Second Quarter 2012 Financial Results & Corporate Updates More...

• Pfizer Inc. (PFE) to Pay $60 Million for Making Foreign Bribes More...

• K-V Pharmaceutical Company (KV-A) "First Day" Motions Approved by U.S. Bankruptcy Court More...

• Novartis AG (NVS) is Staying Put But Selling 12 Acres More...

Drug Trial Failure Hits AstraZeneca PLC (AZN), BTG plc (BGC.L) More...

• Head-to-Head Back Pain Study Finds No Difference Between Eli Lilly and Company (LLY)'s Forteo and Warner Chilcott, PLC (WCRX)'s Actonel More...

• Achillion Pharmaceuticals, Inc. (ACHN) Hepatitis C Drug Shows Promise in Mid-Stage Study More...

• Teva Pharmaceutical Industries Limited (TEVA) to Initiate Third Phase III Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis More...

• Omeros Corporation (OMER) Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial More...

• Eli Lilly and Company (LLY) Last Hope for Alzheimer's Drug as Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pull Out More...

• Perrigo Company (PRGO) Receives FDA Approval and Commences Launch of Morphine Sulfate 100ml/5% Oral Solution More...

• Thinner Diabetics at Higher Death Risk, Northwestern University Feinberg School of Medicine Study More...

• Cholesterol Lowering Drug Can Up Risk of Cataract, University of Waterloo Study More...

• Corticosteroids Not Effective for Treating Acute Sinusitis, University Medical Center Utrecht Study More...

• Hormone May Boost Aging, Failing Brains, University of Washington and VA Puget Sound Health Care System Study More...

• Grapefruit Juice Lowers Dose of Cancer Drug, University of Chicago Study More...

• Did Ranbaxy Laboratories (RANBAXY.BO) Abandon Generic Provigil Launch? More...

• Quick-Med Technologies (QMDT) Announces Expanded Regulatory Clearance for Stay Fresh(R) Antimicrobial More...